MaxArc Global Health Impact Platform

Program Performance & Results Accountability

Results accountability · Targets vs actuals · Evidence & verification

From targets to verified results — with evidence, not assertions.

A polished program-performance and results-accountability view: targets versus actuals, data quality, verification status, underperformance drivers, corrective actions, milestones, and outcomes across grants, countries, facilities, and diseases. Unverified or incomplete results are never presented as final. AI flags anomalies and reconciles records; authorized humans certify, decide, and close.

You are viewing the Program Performance & Results Accountability Dashboard
Accountability posture: Every reported result identifies its indicator, reporting period, responsible entity, data source, and evidence. Target and baseline changes are versioned and auditable. Data-quality issues are never silently corrected. Underperformance is attributable, classified, and escalated where required. Corrective actions require an owner, due date, status, and evidence. Verification status is explicit; unverified or incomplete results are never presented as final. Material variances require documented explanation. Milestone changes require authorization and audit history. Historical performance data is never silently deleted or rewritten. Suspected fabrication, duplicate reporting, denominator manipulation, unsupported results, and selective omission are flagged for authorized human review. This is an operational accountability dashboard, not an official reporting submission.
Active programs 3

Programs under monitoring

Indicators 6

Total tracked indicators

On target 3

Within 5% of target

Below target 3

More than 5% below

Severe underperformance 1

Escalation candidates

Overdue reporting 1

Past reporting due date

Incomplete submissions 2

Completeness < 100%

Data-quality exceptions 2

Below quality threshold

Unverified results 2

Not yet verified

Results not final 2

Not presented as final

Corrective actions open 3

Open / in progress

Corrective actions overdue 1

Past due date

Milestone completion 33%

Milestones completed

Evidence completeness 71%

Results with evidence

AI risk signals 4

Human decision required

Target vs actual results

Every result identifies its indicator, reporting period, responsible entity, data source, and evidence. Percentage indicators carry numerator/denominator provenance. Unverified results are marked "not final".

IndicatorTargetActualVarianceVerificationEvidence / flags
Nets distributed to targeted households
2026 Q2 · Partner Alpha (synthetic) · District Referral Hospital (synthetic)
20,000 19,100
num/den: —
-4.5% verified evidence
Suspected malaria cases tested
2026 Q2 · Partner Alpha (synthetic) · Riverside Health Center (synthetic)
95 71
num/den: 7,100/10,000
-25.3% verified evidence
PLHIV on ART
2026 Q2 · Partner Beta (synthetic) · District Referral Hospital (synthetic)
15,000 14,200
num/den: —
-5.3% verified evidence
Viral load suppression
2026 Q2 · Partner Beta (synthetic) · District Referral Hospital (synthetic)
90 92
num/den: 4,600/5,000
+2.2% verified evidence
TB treatment success rate
2026 Q2 · Partner Beta (synthetic) · Hilltop Community Clinic (synthetic)
88 74
num/den: 740/1,000
-15.9% unverified not final no evidence
TB cases notified
2026 Q2 · Partner Beta (synthetic) · Hilltop Community Clinic (synthetic)
1,200 1,980
num/den: —
+65% disputed not final no evidence improbable increase possible duplicate reporting

Data quality

Data-quality issues are surfaced, never silently corrected.

ResultCompleteTimelinessScoreStatus
RES-MAL-01-Q2 100% on-time 96 acceptable
RES-MAL-02-Q2 100% on-time 90 acceptable
RES-TB-01-Q2 80% late 62 exception
missing evidence and late submission
RES-TB-02-Q2 70% on-time 48 exception
improbable value; denominator not provided

Underperformance

Attributable, classified, and escalated where required.

IndicatorSeverityVarianceRoot causeEscalation
Suspected malaria cases tested severe -25.3% commodity-stockout
supply-driven · IP-ALPHA / FAC-RIVER
escalated human review
TB treatment success rate moderate -15.9% loss-to-follow-up
service-delivery · IP-BETA / FAC-HILL
open human review
PLHIV on ART minor -5.3% seasonal
demand-driven · IP-BETA / FAC-DIST
monitor

Corrective actions

  • Emergency RDT resupply and stock-monitoring at FAC-RIVER — owner program-manager, due 2026-08-15, in-progress
  • Community follow-up and treatment adherence support at FAC-HILL — owner program-manager, due 2026-06-30, overdue no evidence
  • Obtain source documents for disputed TB notification figure — owner me-officer, due 2026-07-20, open no evidence

Milestones

  • Mass net campaign completed (Malaria Program) — target 2026-06-30 completed
  • Differentiated ART service scale-up (HIV Program) — target 2026-09-30 on-track
  • TB active case-finding expansion (TB Program) — target 2026-06-30 delayed

Outcome & impact

  • Confirmed malaria incidence per 1000 — baseline 210, current 176, target 150 improving
    declining incidence trend, below-target pace
  • Viral load suppression among ART patients (%) — baseline 78, current 92, target 90 improving
    target achieved
  • TB treatment success rate (%) — baseline 82, current 74, target 88 worsening
    regression requires corrective action

Variance distribution

  • on or above 2
  • 0 to 10 below 2
  • 10 to 20 below 1
  • over 20 below 1

Anti-fabrication & anti-manipulation signals (AI-assisted, human-decided)

  • improbable increase (RES-TB-02-Q2) — TB notifications 65% above target with no denominator and disputed verification; possible fabrication or duplicate reporting Next: authorized reviewer obtains source documents before any reporting. human decision required
  • unverified result (RES-TB-01-Q2) — TB treatment success reported without evidence and marked not final Next: verify against source register; do not present as final. human decision required
  • severe underperformance (RES-MAL-02-Q2) — Testing coverage 25% below target driven by RDT stockout Next: link to stockpile-logistics stockout; track corrective action. human decision required
  • denominator manipulation watch — Watch for percentage indicators reported without numerator/denominator provenance Next: require numerator/denominator for all percentage indicators. human decision required

AI posture

AI assists with

  • detect anomalous indicator movements
  • identify duplicate or inconsistent reporting
  • flag improbable numerator/denominator patterns
  • detect missing or late submissions
  • compare target, baseline, and result consistency
  • surface underperformance drivers
  • prioritize corrective-action review
  • reconcile grant, facility, partner, and program records
  • summarize trends for authorized reviewers
  • support data-quality triage

AI must never

  • autonomously certify results
  • autonomously change targets, baselines, or reported values
  • autonomously close corrective actions
  • autonomously approve milestone changes
  • autonomously suppress underperformance
  • autonomously publish unverified results
  • bypass human authorization, evidence, or audit controls

AI supports program-performance accountability: it detects anomalous indicator movements, identifies duplicate or inconsistent reporting, flags improbable numerator/denominator patterns, detects missing or late submissions, compares target/baseline/result consistency, surfaces underperformance drivers, prioritizes corrective-action review, reconciles grant/facility/partner/program records, summarizes trends for authorized reviewers, and supports data-quality triage. AI never certifies results, changes targets/baselines/reported values, closes corrective actions, approves milestone changes, suppresses underperformance, publishes unverified results, or bypasses human authorization, evidence, or audit controls.

Runtime boundary & linkage

  • Impact runtime: impact.maxarchealth.com on 127.0.0.1:3201.
  • Linked to fund accountability, stockpile & logistics, lab operations, patient continuity, and asset management without coupling to MaxTrax EHR.
  • Medical Library boundary remains separate at library.maxarchealth.com (port 3101) and is not used here.
  • MaxTrax EHR remains separate; this is not a full EHR.
  • Legacy routes /programs and /performance-indicators remain available and unchanged.
  • This is an operational accountability dashboard, not an official reporting submission.